Join to View Full Profile
4940 Eastern AvenueSuite 1201Baltimore, MD 21224
Phone+1 410-550-5624
Fax+1 410-550-7694
Dr. Polydefkis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityMHS, Clinical Investigation /Mph, 2005 - 2008
Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 1998 - 1999- Johns Hopkins UniversityResidency, Neurology, 1995 - 1998
- Johns Hopkins UniversityResidency, Internal Medicine, 1993 - 1995
- Johns Hopkins University School of MedicineClass of 1993
Certifications & Licensure
MD State Medical License 1998 - 2027
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy Start of enrollment: 2013 Mar 15
- Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD) Start of enrollment: 2012 Nov 01
Publications & Presentations
PubMed
- Evaluation of Nicotinamide Riboside in Prevention of Small Nerve Fiber Axon Degeneration and Promotion of Nerve Regeneration.Simone Thomas, Remi Ben-Davies, Aysel Cetinkaya-Fisgin, Xindan Hu, Xiaoling Li
Journal of the Peripheral Nervous System. 2026-03-01 - 1 citationsA comparison of single versus combination mechanism treatment for transthyretin amyloid cardiomyopathy.Vrinda Gupta, Lisa R Yanek, Bairavi Shankar, Artrish Jefferson, Daniel Tsottles
Amyloid. 2026-03-01 - 1 citationsNeuropathy impairment and nutritional status with eplontersen in patients with hereditary transthyretin-mediated amyloidosis.Jonas Wixner, Isabel Conceição, John L Berk, David Adams, Michael J Polydefkis
Amyloid. 2026-03-01
Press Mentions
Small Fiber Neuropathy: What the Rheumatologist Needs to KnowAugust 26th, 2025- Mouth-Watering Possibilities in Sjögren’s DiseaseAugust 24th, 2025
- Spinal Cord Stimulation May Ease Diabetic NeuropathyMarch 1st, 2023
Grant Support
- Efficacy And Safety Of Fk1706National Center For Research Resources2007
- Gabapentin And Tramadol In The Treatment Of Small Fiber Predominant NeuropathyNational Center For Research Resources2005–2006
- Topiramate Versus Placebo In A Capsaicin Nerve Injury ModelNational Center For Research Resources2004–2005
- A Trial Of Gabapentin In Restless Legs SyndromeNational Center For Research Resources2004–2005
- Human Axonal Regeneration In Diabetic NeuropathyNational Institute Of Neurological Disorders And Stroke2001–2005
Professional Memberships
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/michael-polydefkis
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
